Among older adults discharged to a skilled nursing facility after surgery who received a new gabapentinoid prescription, 38% demonstrated prolonged use.
Cohort (n=79,417)
Yes
What is the rate and what are the predictors of prolonged gabapentinoid use in older adults discharged to a skilled nursing facility and then home after surgery?
A significant proportion (38%) of older adults newly prescribed gabapentinoids after surgery and discharged to a SNF experience prolonged use, highlighting a need for interventions to prevent inappropriate continuation.
ABSTRACT Background The number of older adults being discharged to a skilled nursing facility (SNF) after surgery continues to rise. Prior studies have shown that gabapentinoid prescribing after surgery is increasing, though this work only studied patients transitioning from hospital to home. Therefore, we aim to describe both use and prolonged use of gabapentinoids for older adults who are discharged to SNF and then home after surgery. Methods We conducted a retrospective analysis by merging patient data from Medicare Carrier, MedPAR, and Outpatient Files with Medicare Part D for 2013–2020. We included patients ≥ 66 years at time of procedure undergoing one of 14 common surgeries performed in older adults whose discharge was to SNF then home. Results The total study cohort included 79,417 patients who were discharged to a SNF. Median length of SNF stay was 15 days (IQR 10, 22 days). A total of 3182 (4%) received a new gabapentinoid prescription. Of these, 38% ( n = 1219) had prolonged use. On multivariable logistic regression, we found that female sex, gabapentinoid days supply, emergency surgery, non‐orthopedic and nonvascular surgery, and higher area deprivation index were associated with prolonged use. Conclusions Of our cohort, 38% had prolonged use, more than 1.5 times the proportion of prolonged use found in a past study among patients being discharged directly home. Importantly, patients who were sicker and more disadvantaged were more likely to have prolonged use. Our study highlights that additional work needs to focus on understanding and preventing inappropriate prolonged use of gabapentinoids after SNF discharge.
Bongiovanni et al. (Sat,) conducted a cohort in Postoperative discharge to skilled nursing facility (n=79,417). New gabapentinoid prescription was evaluated on Prolonged use of gabapentinoids. Among older adults discharged to a skilled nursing facility after surgery who received a new gabapentinoid prescription, 38% demonstrated prolonged use.